The Merck Group Website
The Merck Group Website
Why do companies partner with EMD Serono?

Why do companies partner with EMD Serono?

Steven, Head of Business Development, North America, Head of Global Business Development, Fertility and...more

Steven, Head of Business Development, North America, Head of Global Business Development, Fertility and Endocrinology: "Our organization has a strong entrepreneurial spirit that helps us make the most of the external opportunities to develop new drugs."

Partnering with Us

Success Through Partnerships

At EMD Serono, Inc. we are committed to success through partnerships. We achieve this through dedicated alliance managers, joint project teams, a governance structure facilitating decision-making, open communications and an unfailing pursuit of common goals. That commitment, and our ability to deliver on it, makes EMD Serono the partner of choice.
Partnering with other biotechnology and pharmaceutical companies, as well as leading academic institutions, is a core part of our strategy. By combining complementary expertise and resources, we create an environment that enables us to enhance value and move our projects forward. This helps us to bring therapeutic innovations to patients more quickly.
EMD Serono is an affiliate Merck KGaA, Darmstadt, Germany. Along with Merck Serono, as the division is known outside of North America, we offer potential partners a solid foundation upon which to build mutually rewarding relationships.
Here is a listing of key partnerships with Merck KGaA, and its affiliates Merck Serono and EMD Serono, Inc.:
Global Partnerships
AblynxEcole Polytechnique Federal de Lausanne (EPFL)Oncothyreon
AmbrxEmmausOSI (US only)
AngiosynFast ForwardPfizer (US only)
ApitopeFlamelPasteur Institute
BioMarinForestRegeneron
BionomicsIderaScripps Research Institute
BioVascularImmunovaccine Inc.SRD Pharmaceuticals
BioWaLillyTaiho Pharmaceuticals
BMBFMassachusetts General HospitalTargeGene
Brigham & Women's HospitalMax Planck InstituteTheratechnologies (US only)
Bristol-Myers Squibb (BMS)M.D. AndersonTioga
Cardiff UniversityMichael J. Fox FoundationUniversity of Dundee/Academic Consortium
ChemDivMitsubishi Tanabe PharmaWeizmann Institute of Science
Clinical Data, Inc.MSM Protein TechnologiesZymoGenetics
Daninippon SumitomoNewron
DyaxNippon Shinyaku

PARTNERING PROPOSALS

We are actively seeking to expand our current pipeline of opportunities, which represents a major part of our current development portfolio. Every proposal is considered by our global search and evaluation team, who are committed to bringing innovative products to the market.